COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies.
clinical trials
coronovirus
covid-19
mrna-based vaccine
sars-cov-2
vaccine development
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
20 May 2020
20 May 2020
Historique:
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
COVID-19, which was first detected in the Hubei province of China, has become a global phenomenon. The effects and devastation on both health and economy have been global. At present, there is a substantial amount of research being done to discover suitable treatment modalities. Efforts have been made on the development of potential efficacious vaccines. The development of a vaccine can be complex, expensive as well as time-consuming. Currently, various ongoing clinical trials are in progress that are investigating either pharmacologic therapies or vaccines against this virus. We, in this brief review have tried to address the process and current development efforts of vaccine in progress.
Identifiants
pubmed: 32577324
doi: 10.7759/cureus.8206
pmc: PMC7305574
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e8206Informations de copyright
Copyright © 2020, Khan et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Immunome Res. 2010 Nov 03;6 Suppl 2:S5
pubmed: 21067547
Clin Exp Vaccine Res. 2015 Jan;4(1):46-53
pubmed: 25648742
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Cell Mol Life Sci. 2016 Dec;73(23):4433-4448
pubmed: 27392606
Immunol Rev. 2013 Sep;255(1):230-42
pubmed: 23947359
J Postgrad Med. 2016 Jan-Mar;62(1):4-11
pubmed: 26732191
JAMA. 2020 Apr 13;:
pubmed: 32282022
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466